Approved with 99.89% support, the proposal updates issuance and buyback parameters that govern how INJ is removed from circulation over time. Injective’s protocol community approved a major tokenomics ...

Four and a half years ago, Eric Chen and Albert Chon, the founders of financial blockchain company Injective, achieved a feat many entrepreneurs only dream of: They landed Mark Cuban as an investor.

Toronto, Ontario--(Newsfile Corp. - November 20, 2025) - Pineapple Financial Inc. (NYSE American: PAPL) ("Pineapple" or "the Company"), a leading fintech platform, today announced the formation of a ...

The cryptocurrency market remained weak on Wednesday, as Bitcoin continued to struggle around $90,000. Altcoins display mixed performances after the latest crash violated key price levels. This ...

Layer-1 blockchain Injective has rolled out what it calls its most significant upgrade yet: a native Ethereum Virtual Machine (EVM) layer. The upgrade aims to make Injective a go-to platform for ...

Injective, the blockchain built for finance, has launched iBuild, a Web3 platform that enables anyone to build and deploy blockchain applications without writing code. Powered by Injective’s MultiVM ...

Injective is the interoperable layer one (L1) blockchain operating at the intersection of DeFi and TradFi. Its ecosystem offers a full suite of products for developers and end-users, including ...

Injective Labs' Business Institutional Lead Cooper Emmons believes that crypto’s next major leap isn’t another memecoin cycle — it’s the migration of global financial markets onto the blockchain. In a ...

Investing.com -- Cryptocurrency Injective (INJ) now has its second exchange-traded fund in development after 21Shares filed paperwork with the Securities and Exchange Commission for an Injective ETF ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Korean researchers have developed the world’s first gene-editing injection that can correct mutations causing hereditary deafness, offering new hope for children who have relied only on hearing aids ...